Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report
- PMID: 15781098
- DOI: 10.1016/S0140-6736(05)71139-9
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report
Abstract
Background: Rapid progression to AIDS after acute HIV-1 infection, though uncommon, has been noted, as has the transmission of multidrug resistant viruses. Here, we describe a patient in whom these two factors arose concomitantly and assess the effects.
Methods: We did a case study of a patient with HIV-1 seroconversion. We genotyped the virus and host genetic markers by PCR and nucleotide sequencing. To ascertain the drug susceptibility of our patient's HIV-1 we did phenotypic studies with the PhenoSense assay. We assessed viral coreceptor use via syncytium formation in vitro and with a modified PhenoSense assay.
Findings: Our patient seems to have been recently infected by a viral variant of HIV-1 resistant to multiple classes of antiretroviral drugs. Furthermore, his virus population is dual tropic for cells that express CCR5 or CXCR4 coreceptor. The infection has resulted in progression to symptomatic AIDS in 4-20 months.
Interpretation: The intersection of multidrug resistance and rapid development of AIDS in this patient is of concern, especially in view of his case history, which includes high-risk sexual contacts and use of metamfetamine. The public health ramifications of such a case are great.
Comment in
-
HIV/AIDS: doing what's right.Lancet. 2005 Mar 19-25;365(9464):1003. Lancet. 2005. PMID: 15789450 No abstract available.
-
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.Lancet. 2005 Jun 4-10;365(9475):1923-4; author reply 1924. doi: 10.1016/S0140-6736(05)66651-2. Lancet. 2005. PMID: 15936412 No abstract available.
-
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.Lancet. 2005 Jun 4-10;365(9475):1923; author reply 1924. doi: 10.1016/S0140-6736(05)66650-0. Lancet. 2005. PMID: 15936413 No abstract available.
-
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.Lancet. 2005 Jun 4-10;365(9475):1924-5. doi: 10.1016/S0140-6736(05)66653-6. Lancet. 2005. PMID: 15936414 No abstract available.
Similar articles
-
Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba. AIDS. 2008. PMID: 18614865
-
HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report.Clin Infect Dis. 2007 Aug 15;45(4):501-9. doi: 10.1086/520024. Epub 2007 Jul 10. Clin Infect Dis. 2007. PMID: 17638203
-
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.Lancet. 2005 Jun 4-10;365(9475):1923; author reply 1924. doi: 10.1016/S0140-6736(05)66650-0. Lancet. 2005. PMID: 15936413 No abstract available.
-
Maraviroc, a CCR5 coreceptor antagonist that blocks entry of human immunodeficiency virus type 1.Pharmacotherapy. 2009 Mar;29(3):295-304. doi: 10.1592/phco.29.3.295. Pharmacotherapy. 2009. PMID: 19249948 Review.
-
Genotypic coreceptor analysis.Eur J Med Res. 2007 Oct 15;12(9):453-62. Eur J Med Res. 2007. PMID: 17933727 Review.
Cited by
-
Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan.Sci Rep. 2022 Oct 13;12(1):17195. doi: 10.1038/s41598-022-22163-7. Sci Rep. 2022. PMID: 36229577 Free PMC article.
-
Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs.Polymers (Basel). 2022 Jul 29;14(15):3090. doi: 10.3390/polym14153090. Polymers (Basel). 2022. PMID: 35956604 Free PMC article. Review.
-
The association between methamphetamine use and number of sexual partners in men who have sex with men: a systematic review and meta-analysis.Subst Abuse Treat Prev Policy. 2022 Apr 9;17(1):27. doi: 10.1186/s13011-022-00453-7. Subst Abuse Treat Prev Policy. 2022. PMID: 35397571 Free PMC article.
-
Transmitted and Acquired HIV-1 Drug Resistance from a Family: A Case Study.Infect Drug Resist. 2020 Oct 22;13:3763-3770. doi: 10.2147/IDR.S272232. eCollection 2020. Infect Drug Resist. 2020. PMID: 33122923 Free PMC article.
-
Enhancing the ligand efficiency of anti-HIV compounds targeting frameshift-stimulating RNA.Bioorg Med Chem. 2019 Jul 1;27(13):2972-2977. doi: 10.1016/j.bmc.2019.05.009. Epub 2019 May 9. Bioorg Med Chem. 2019. PMID: 31101492 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
